two
novel
coronavirus
emerg
caus
sever
diseas
human
bat
may
primari
reservoir
virus
sar
coronaviru
sarscov
like
cross
human
civet
china
mer
coronaviru
merscov
transmit
camel
middl
east
unlik
sarscov
resolv
within
year
continu
introduct
merscov
present
ongo
public
health
threat
anim
model
need
evalu
countermeasur
emerg
virus
sarscov
sever
anim
speci
permiss
infect
contrast
laboratori
anim
refractori
semipermiss
infect
merscov
hostrang
restrict
larg
determin
sequenc
heterogen
merscov
receptor
describ
anim
model
develop
studi
coronavirus
focu
hostrang
restrict
level
viral
receptor
discuss
approach
consid
develop
model
evalu
countermeasur
merscov
within
last
two
decad
sever
introduct
zoonot
pathogen
human
popul
specif
two
novel
coronavirus
cov
sever
acut
respiratori
syndromecov
sarscov
middl
east
respiratori
syndromecov
merscov
caus
signific
concern
cross
speci
barrier
caus
sever
diseas
sarscov
origin
asia
spread
rapidli
sever
countri
throughout
world
merscov
larg
restrict
infect
acquir
middl
east
virus
associ
spread
person
person
high
casefat
rate
thu
develop
anim
model
evalu
antivir
therapi
vaccin
high
prioriti
sarscov
emerg
guangdong
provinc
southern
china
novemb
sever
acut
respiratori
syndrom
sar
retrospect
analysi
identifi
case
novemb
march
document
contact
wild
anim
chines
smec
zhong
et
al
peiri
et
al
februari
infect
person
travel
hong
kong
stay
hotel
tsang
et
al
hotel
spread
viru
sever
visitor
return
home
countri
canada
ireland
unit
state
vietnam
singapor
start
global
sarscov
epidem
peiri
et
al
tsang
et
al
poutanen
et
al
ruan
et
al
ksiazek
et
al
total
sarscov
case
fatal
report
result
coordin
public
health
effort
involv
screen
isol
contact
trace
quarantin
effort
human
chain
transmiss
sarscov
broken
booth
et
al
chan
et
al
donnelli
et
al
karlberg
et
al
sinc
end
outbreak
incid
laboratoryacquir
sarscov
infect
normil
vogel
normil
liang
et
al
two
week
decemb
januari
individu
guangzhou
china
becam
infect
sarscov
none
patient
die
infect
viru
transmit
contact
liang
et
al
sinc
earli
sarscov
reemerg
new
communityacquir
infect
report
howev
close
relat
coronavirus
identifi
bat
least
one
bat
viru
abl
bind
human
receptor
infect
human
cell
ge
et
al
lau
et
al
contrast
merscov
outbreak
ongo
merscov
initi
isol
sever
ill
patient
jeddah
saudi
arabia
june
bermingham
et
al
sinc
continu
report
new
infect
geograph
distinct
region
suggest
separ
zoonot
introduct
secondari
transmiss
healthcar
worker
famili
member
also
report
estim
case
repres
secondari
infect
altawfiq
memish
earli
decemb
laboratori
confirm
case
merscov
infect
death
report
ecdc
merscov
infect
report
least
countri
middl
east
includ
saudi
arabia
unit
arab
emir
uae
qatar
oman
jordan
kuwait
yemen
lebanon
iran
isol
incid
infect
travel
return
countri
europ
south
east
asia
unit
state
reusken
et
al
reusken
et
al
meyer
et
al
nowotni
kolodziejek
alagaili
et
al
hemida
et
al
haagman
et
al
memish
et
al
azhar
et
al
adney
et
al
sarscov
merscov
belong
order
nidoviral
famili
coronaviru
betacoronavirus
belong
lineag
b
c
sever
acut
respiratori
syndrom
sar
lau
et
al
zaki
et
al
member
coronavirida
famili
virus
host
cell
deriv
lipid
envelop
contain
nonseg
positivestrand
rna
genom
master
perlman
van
boheemen
et
al
viral
genom
encod
seri
nest
subgenom
rna
express
multipl
gene
product
coronavirus
attach
enter
cell
via
interact
spike
protein
cell
surfac
receptor
sarscov
human
angiotensinconvert
enzym
identifi
cellular
receptor
jeffer
et
al
predomin
receptor
much
lower
affin
protein
jeffer
et
al
cell
surfac
receptor
merscov
human
dipeptidi
peptidas
also
known
sar
merscov
protein
hostreceptor
interact
consid
major
determin
host
restrict
master
perlman
virus
close
relat
coronavirus
identifi
bat
batsarscov
chines
horsesho
bat
sarscov
lau
et
al
merscov
lau
et
al
zaki
et
al
bat
may
primari
reservoir
merscov
surveil
studi
found
high
rate
seroposit
dromedari
camel
sever
middl
eastern
countri
reusken
et
al
reusken
et
al
meyer
et
al
nowotni
kolodziejek
alagaili
et
al
hemida
et
al
indic
camel
play
role
reservoir
strengthen
studi
identifi
merscov
rna
nasal
swab
camel
farm
associ
human
case
haagman
et
al
addit
studi
camel
isol
directli
link
fatal
human
case
saudi
arabia
azhar
et
al
furthermor
experiment
infect
dromedari
camel
demonstr
could
product
infect
shed
high
titer
viru
nasal
secret
adney
et
al
howev
rel
role
camel
bat
reservoir
merscov
remain
determin
fda
anim
efficaci
rule
anim
rule
therapeut
rare
emerg
virul
agent
achiev
regulatori
approv
provid
efficaci
demonstr
two
anim
model
one
must
nonrod
speci
anim
speci
interest
must
first
evalu
permiss
viral
replic
present
clinic
diseas
altern
anim
speci
permiss
show
clinic
diseas
serial
passag
perform
anim
model
develop
result
diseas
must
character
ideal
anim
model
permiss
infect
reproduc
clinic
ill
patholog
observ
human
sarscov
sever
anim
speci
evalu
model
human
diseas
laboratori
anim
includ
mice
hamster
ferret
nonhuman
primat
could
product
infect
speci
display
overt
clinic
diseas
follow
serial
adapt
sarscov
mice
robert
et
al
engin
transgen
mice
express
human
mccray
et
al
yang
et
al
obstacl
partial
overcom
develop
murin
model
enabl
efficaci
studi
antivir
agent
sever
vaccin
sarscov
hilgenfeld
peiri
graham
et
al
contrast
sever
anim
speci
evalu
merscov
except
primat
speci
anim
resist
infect
herein
describ
anim
model
sar
merscov
focu
role
host
receptor
conclud
discuss
approach
could
use
develop
anim
model
merscov
anim
model
infecti
diseas
serv
two
key
purpos
character
viral
pathogenesi
evalu
antivir
agent
vaccin
context
infecti
diseas
feasibl
ethic
perform
clinic
trial
anim
studi
play
addit
role
fda
anim
efficaci
rule
anim
rule
therapeut
rare
emerg
virul
agent
achiev
regulatori
approv
provid
efficaci
demonstr
two
anim
model
one
must
nonrod
speci
display
clinic
ill
repres
human
diseas
fda
ideal
anim
model
permiss
infect
reproduc
clinic
cours
patholog
observ
human
algorithm
develop
anim
model
present
fig
small
anim
model
offer
sever
advantag
nhp
includ
avail
anim
speci
specif
reagent
eas
handl
reduc
cost
abil
use
suffici
number
statist
analysi
especi
coronavirus
rodent
vari
suscept
may
semipermiss
infect
refractori
clinic
diseas
even
use
screen
countermeasur
bisht
et
al
buchholz
et
al
thu
gener
rodent
model
display
clinic
diseas
may
necessari
adapt
viru
enhanc
virul
rodent
host
gener
transgen
anim
pathogenesi
model
fulli
character
diseas
mechan
adapt
viru
transgen
anim
may
differ
natur
host
fig
nhp
close
relat
human
invalu
anim
model
sinc
studi
nhp
incur
signific
expens
investig
choos
screen
therapi
small
anim
model
perform
limit
primat
studi
import
note
sever
speci
subspeci
nhp
result
signific
variat
level
viral
replic
clinic
diseas
thu
sever
speci
must
often
evalu
yield
suitabl
anim
model
collect
develop
anim
model
rodent
nhp
fundament
studi
infecti
diseas
lead
develop
countermeasur
sever
zoonot
pathogen
sever
inbr
mous
strain
evalu
model
sarscov
infect
glass
et
al
hogan
et
al
wentworth
et
al
initi
studi
week
old
balbc
mice
demonstr
viru
dose
median
tissu
cultur
infecti
dose
tcid
urbani
strain
given
intranas
result
product
infect
peak
titer
day
resolut
day
mice
lose
weight
display
sign
clinic
diseas
develop
pulmonari
patholog
studi
mice
yield
similar
result
lack
clinic
diseas
clearanc
viru
day
knockout
mice
background
includ
beig
strain
lack
nk
cell
function
nkt
cell
respect
mice
lack
b
lymphocyt
also
develop
clinic
diseas
viral
kinet
similar
beig
mice
mice
glass
et
al
similarli
mice
display
peak
viral
replic
day
clearanc
day
develop
clinic
ill
histopatholog
examin
show
evid
selflimit
bronchiol
patchi
interstiti
pneumonia
contrast
diseas
progress
significantli
alter
mice
background
mice
display
progress
weight
loss
bronchiol
progress
interstiti
pneumonia
mediastin
viral
replic
peak
day
persist
day
postinfect
indic
type
ifn
respons
requir
control
sarscov
infect
although
mice
show
evid
infect
lung
diseas
inbr
mous
strain
accur
reproduc
diffus
alveolar
damag
edema
pneumocyt
necrosi
hyalin
membran
format
observ
human
ding
et
al
frank
et
al
nichol
et
al
model
epidemiolog
find
advanc
age
result
increas
mortal
age
mous
model
sarscov
develop
model
month
old
balbc
mice
support
high
level
viral
replic
lung
day
resolut
day
strain
mice
lose
weight
day
age
balbc
mice
display
ruffl
fur
dehydr
robert
et
al
contrast
age
mice
support
prolong
pulmonari
viral
replic
clear
viru
day
regardless
age
mous
strain
display
similar
histopatholog
featur
earli
infect
ie
day
includ
perivascular
peribronchiolar
mononuclear
infiltr
necrot
debri
bronchiol
foci
interstiti
pneumon
robert
et
al
day
postinfect
age
balbc
mice
display
promin
perivascular
infiltr
alveolar
damag
persist
day
robert
et
al
collect
patholog
chang
observ
age
mous
model
close
resembl
observ
human
result
age
mice
use
extens
young
mice
develop
mous
model
sarscov
infect
associ
mortal
transgen
mice
express
human
gener
mccray
et
al
yang
et
al
netland
et
al
tseng
et
al
gener
diseas
sever
transgen
mice
correl
level
express
transgen
mice
express
control
cytokeratin
promot
high
level
mrna
lung
liver
colon
kidney
mccray
et
al
netland
et
al
mice
challeng
sarscov
develop
sever
infect
begin
airway
epithelium
spread
brain
infect
result
weight
loss
begin
day
mortal
day
mccray
et
al
netland
et
al
use
altern
approach
express
control
chicken
betaactin
promot
cytomegaloviru
ie
enhanc
transgen
mous
line
differ
level
gener
tseng
et
al
infect
mice
high
level
express
similarli
yield
sever
lung
brain
infect
mortal
contrast
infect
mice
express
lower
level
result
clinic
ill
without
associ
mortal
tseng
et
al
find
support
third
model
express
control
mous
promot
result
limit
tissu
distribut
mice
challeng
sarscov
becam
letharg
surviv
infect
yang
et
al
mice
also
show
sever
interstiti
pneumonia
extrapulmonari
organ
damag
suggest
accur
model
human
sarscov
infect
howev
studi
increas
viral
load
viral
antigen
observ
brain
tissu
transgen
mice
mortal
result
extens
dissemin
viru
brain
mccray
et
al
find
contrast
human
diseas
central
nervou
system
infect
rare
observ
thu
transgen
mice
result
lethal
model
sarscov
infect
mous
model
accur
reproduc
diseas
spectrum
observ
sarscov
infect
patient
golden
syrian
hamster
highli
permiss
sarscov
infect
robert
et
al
lamirand
et
al
infect
hamster
sarscov
tcid
urbani
strain
result
product
infect
peak
replic
day
nasal
turbin
lung
viral
clearanc
day
infect
also
result
extrapulmonari
spread
consist
transient
viremia
spread
liver
spleen
proport
anim
viral
replic
accompani
pulmonari
histopatholog
consist
focal
area
interstiti
inflamm
consolid
visibl
day
becom
widespread
day
consolid
involv
lung
robert
et
al
despit
extens
pulmonari
patholog
hamster
display
overt
clinic
diseas
mortal
weight
loss
difficult
assess
hamster
due
storag
food
larg
cheek
pouch
howev
use
run
wheel
rotat
counter
permit
object
measur
nocturn
activ
anim
compar
mockinfect
hamster
preinfect
activ
level
sarscov
infect
hamster
exhibit
greater
reduct
activ
lamirand
et
al
first
object
measur
clinic
ill
hamster
subsequ
studi
hamster
also
shown
suscept
sever
differ
strain
sarscov
strain
includ
urbani
frankfurt
recombin
clone
infect
result
limit
mortal
anim
strain
produc
lethal
infect
collect
studi
demonstr
hamster
repres
suitabl
model
sarscov
infect
although
much
like
young
age
mous
model
mortal
promin
featur
model
liang
et
al
watt
et
al
ferret
repres
excel
model
influenza
infect
result
evalu
suscept
sarscov
infect
ferret
viru
dose
tcid
yield
product
infect
lung
trachea
nasal
turbin
viral
replic
peak
lung
day
reach
level
tcid
ml
lung
homogen
chu
et
al
martina
et
al
ter
meulen
et
al
weingartl
et
al
primari
histopatholog
find
multifoc
pulmonari
lesion
affect
lung
mild
alveolar
damag
peribronchiolar
perivascular
lymphocyt
infiltr
report
clinic
diseas
vari
initi
studi
util
intratrach
administr
infect
ferret
becam
letharg
one
anim
succumb
diseas
studi
util
sarscov
isol
lethargi
prolong
diseas
also
observ
martina
et
al
kobing
et
al
subsequ
report
use
either
intratrach
intranas
administr
lethargi
mortal
observ
chu
et
al
ter
meulen
et
al
weingartl
et
al
darnel
et
al
furthermor
studi
specif
design
assess
ferret
nonrod
model
meet
criteria
fda
anim
rule
clinic
diseas
limit
fever
sneez
larg
group
ferret
inocul
strain
chu
et
al
singl
studi
contact
transmiss
sarscov
uninfect
cage
mate
report
along
conjunct
mortal
day
martina
et
al
histopatholog
analysi
found
evid
hepat
lipidosi
emaci
indic
mortal
associ
sarscov
pneumonia
find
indic
sarscov
could
transmit
low
level
direct
contact
ferret
model
summari
ferret
shown
support
sarscov
replic
vari
degre
clinic
diseas
much
like
rodent
model
sarscov
infect
result
signific
mortal
six
nhp
speci
evalu
model
sarscov
infect
includ
three
old
world
monkey
rhesu
cynomolgu
macaqu
african
green
monkey
three
new
world
monkey
common
marmoset
squirrel
monkey
mustach
tamarin
lawler
et
al
fouchier
et
al
robert
subbarao
mcauliff
et
al
row
et
al
qin
et
al
rockx
et
al
greenough
et
al
except
squirrel
monkey
mustach
tamarin
robert
subbarao
nhp
examin
support
sarscov
replic
initi
studi
perform
cynomolgu
macaqu
demonstr
sarscov
fulfil
koch
postul
studi
viru
isol
nasal
secret
viru
could
detect
lung
sampl
rtpcr
consist
viru
isol
anim
pulmonari
patholog
indic
interstiti
pneumonia
repres
mild
human
diseas
studi
use
cynomolgu
macaqu
rang
clinic
ill
report
observ
rang
skin
rash
decreas
activ
cough
respiratori
distress
absenc
clinic
diseas
lawler
et
al
mcauliff
et
al
row
et
al
rockx
et
al
compar
old
world
monkey
speci
african
green
monkey
cynomolgu
rhesu
macaqu
challeng
parallel
sarscov
urbani
strain
anim
develop
clinic
diseas
three
speci
viral
replic
combin
nasalthroat
swab
tracheal
lavag
sampl
viral
replic
highest
african
green
monkey
follow
cynomolgu
rhesu
macaqu
viral
titer
peak
day
clearanc
upper
lower
respiratori
tract
day
respect
three
speci
produc
neutral
antibodi
antibodi
titer
correl
viru
replic
pulmonari
patholog
examin
african
green
monkey
day
postinfect
consist
featur
interstiti
pneumonia
day
focal
interstiti
mononuclear
inflammatori
infiltr
edema
lung
stain
viral
antigen
identifi
type
pneumocyt
predomin
cell
type
infect
sarscov
day
reduct
amount
viral
antigen
level
inflamm
subsequ
studi
rhesu
macaqu
challeng
sarscov
strain
viru
could
detect
nasal
pharyng
swab
day
pulmonari
histopatholog
similarli
consist
interstiti
pneumonia
qin
et
al
infect
common
marmoset
also
result
mild
clinic
diseas
anim
develop
febril
respons
diarrhea
greenough
et
al
due
technic
challeng
replic
viru
could
isol
lung
homogen
howev
high
level
vrna
detect
lung
sampl
day
postinfect
marmoset
develop
pulmonari
hepat
patholog
evid
interstiti
pneumon
time
point
day
hepat
lesion
start
develop
day
readili
appar
anim
day
day
anim
evid
multifoc
hepat
hepat
lesion
also
observ
human
patient
marmoset
nhp
develop
liver
diseas
greenough
et
al
collect
nhp
speci
permiss
sarscov
infect
model
differ
aspect
human
diseas
african
green
monkey
support
high
level
replic
respiratori
tract
marmoset
model
hepat
patholog
speci
show
evid
interstiti
pneumonia
howev
speci
consist
reproduc
sever
clinic
diseas
mortal
observ
speci
identifi
function
receptor
sarscov
african
green
monkey
deriv
vero
cell
subsequ
crystallographi
studi
identifi
amino
acid
posit
direct
contact
protein
receptorbind
domain
rbd
see
tabl
li
et
al
civet
c
display
affin
human
civet
sarscov
isol
human
h
preferenti
bound
protein
rbd
human
isol
biochem
studi
perform
defin
mutat
influenc
rbd
affin
li
wu
et
al
wu
et
al
li
et
al
studi
identifi
two
region
interact
protein
rbd
mutat
evolv
accommod
switch
prefer
li
wu
et
al
wu
et
al
two
region
design
hotspot
hotspot
hotspot
residu
interact
form
salt
bridg
turn
interact
protein
rbd
contrast
rbd
civet
isol
mutat
lysin
residu
compet
destabil
salt
bridg
diminish
bind
compens
civet
threonin
posit
remov
salt
bridg
structur
destabil
effect
permit
high
affin
bind
li
interact
amino
acid
near
posit
also
found
play
signific
role
affin
lysin
k
posit
interact
aspart
form
second
salt
bridg
format
bridg
requir
addit
support
threonin
protein
rbd
human
sarscov
strain
civet
isol
serin
posit
support
format
salt
bridg
result
decreas
affin
posit
encod
glutam
e
longer
side
chain
aspart
allow
support
format
salt
bridg
absenc
promot
bind
civet
isol
li
context
anim
model
sarscov
infect
interact
protein
rbd
hot
spot
may
partial
explain
vari
level
replic
observ
differ
speci
tabl
compar
amino
acid
interact
protein
rbd
sever
speci
examin
human
agm
macaqu
residu
speci
ident
interact
residu
marmoset
hamster
residu
similar
agreement
permiss
natur
speci
contrast
mani
residu
mous
differ
human
li
et
al
correspond
reduc
replic
sarscov
mous
cell
li
et
al
lung
young
mice
mice
semipermiss
sarscov
rat
support
replic
sarscov
two
chang
rel
human
posit
mous
rat
predict
account
differ
replic
li
et
al
mice
rat
histidin
posit
compar
partial
disrupt
interact
li
et
al
moreov
asparagin
n
rat
introduc
glycosyl
site
block
interact
posit
residu
protein
rbd
contrast
mous
serin
posit
though
suboptim
prevent
interact
protein
togeth
combin
chang
posit
lead
ineffici
bind
protein
reduc
permiss
mous
cell
glycosyl
site
residu
rat
abrog
bind
li
et
al
examin
hamster
sequenc
posit
also
reveal
asparagin
n
residu
examin
surround
amino
acid
residu
indic
presenc
glycosyl
site
surpris
hamster
highli
permiss
sarscov
howev
inhibitori
effect
may
overcom
multipl
addit
interact
ie
share
human
hamster
tempt
specul
hamster
may
develop
lethal
pronounc
clinic
diseas
amino
acid
residu
posit
similar
interest
ferret
interact
residu
differ
thu
surpris
ferret
permiss
sarscov
infect
compar
civet
ferret
mani
residu
experiment
studi
shown
civet
infect
human
isol
wu
et
al
thu
ferret
may
differ
similar
may
result
affin
ferret
protein
rbd
permit
infect
replic
summari
structur
analysi
protein
interact
agre
observ
improv
replic
sever
anim
model
howev
find
fulli
explain
host
restrict
limit
clinic
diseas
observ
anim
model
despit
high
degre
similar
nhp
sequenc
nhp
recapitul
human
diseas
within
nhp
speci
variat
level
viral
replic
furthermor
age
mice
develop
diseas
support
replic
despit
reduc
affin
protein
rbd
thu
clear
interact
proteinrbd
requir
effici
infect
replic
addit
host
factor
like
also
contribut
develop
sever
diseas
altern
evalu
multipl
anim
speci
anoth
strategi
gener
anim
model
clinic
diseas
adapt
viru
new
host
serial
passag
fig
gener
mous
model
associ
mortal
sarscov
urbani
strain
serial
passag
lung
young
balbc
mice
robert
et
al
passag
singl
viru
clone
isol
caus
mortal
young
week
old
week
old
age
balbc
mice
viru
design
site
play
import
role
host
rang
cross
speci
infect
indic
bold
type
underlin
sever
diseas
result
overwhelm
viral
infect
significantli
higher
titer
prolong
replic
lung
accompani
extens
damag
bronchiolar
alveolar
epitheli
cell
robert
et
al
also
capabl
extrapulmonari
spread
evid
viremia
recoveri
viru
spleen
liver
brain
tissu
sequenc
analysi
revers
genet
studi
identifi
amino
acid
mutat
associ
lethal
phenotyp
mutat
includ
chang
singl
chang
protein
protein
particular
interest
mutat
protein
locat
protein
rbd
followup
studi
rel
contribut
mutat
defin
use
panel
recombin
virus
frieman
et
al
revers
four
mutat
alter
virul
howev
revers
locat
protein
mutat
result
reduc
weight
loss
less
protein
mutat
respect
furthermor
revers
protein
mutat
result
nonleth
infect
clinic
diseas
introduct
protein
mutat
either
alon
combin
urbani
infecti
clone
fail
induc
lethal
infect
young
balbc
mice
indic
protein
mutat
necessari
suffici
induc
sever
diseas
given
mutat
present
addit
mutat
gene
may
lead
enhanc
diseas
promot
interact
host
cell
protein
involv
viral
replic
frieman
et
al
zornetz
et
al
altern
mutat
may
also
alter
host
respons
stat
mice
progress
rapidli
termin
endpoint
inocul
compar
wildtyp
viru
develop
addit
mouseadapt
viru
strain
urbani
strain
similarli
passag
time
two
separ
studi
yield
lethal
viru
strain
term
strain
frieman
et
al
day
et
al
direct
comparison
infect
strain
result
significantli
higher
pulmonari
viru
titer
enhanc
mortal
lower
dose
ten
amino
acid
chang
associ
adapt
mutat
aros
protein
specif
second
mutat
identifi
rbd
addit
mutat
rbd
found
sampl
found
lung
infect
mice
two
remain
protein
mutat
locat
outsid
rbd
heptad
repeat
element
day
et
al
sequenc
strain
reveal
amino
acid
mutat
two
chang
protein
bind
domain
frieman
et
al
chang
aros
mous
adapt
protein
rbd
predict
enhanc
affin
bind
protein
human
sarscov
strain
residu
protein
interact
residu
interact
within
hotspot
bind
influenc
residu
mutat
interfer
interact
protein
rbd
thu
mutat
aros
serial
passag
overcom
interfer
frieman
et
al
promot
enhanc
bind
strain
two
mutat
evolv
rbd
mutat
predict
form
polar
interact
chang
remov
bulki
side
chain
permit
access
enhanc
bind
frieman
et
al
strain
contain
mutat
describ
mutat
like
compens
extent
steric
clash
describ
howev
chang
remov
hydroxyl
group
bind
interfac
predict
enhanc
interact
frieman
et
al
mous
adapt
studi
yield
sever
sarscov
strain
capabl
caus
lethal
diseas
mice
strain
repres
advanc
develop
anim
model
anim
rule
though
diseas
mechan
young
mice
differ
human
use
viru
age
mice
prove
valuabl
model
studi
sarscov
vaccin
candid
studi
examin
mutat
aros
upon
serial
passag
detail
analysi
protein
interact
emphas
role
protein
host
restrict
demonstr
proteinhost
receptor
interact
critic
develop
anim
model
emphas
find
transgen
mice
express
mouseadapt
sarscov
strain
show
enhanc
replic
diseas
understand
hostreceptor
interact
develop
applic
knowledg
facilit
develop
anim
model
emerg
coronavirus
wildtyp
mice
knockout
strain
evalu
model
merscov
infect
coleman
et
al
studi
eight
weekold
balbc
mice
intranas
inocul
tcid
none
mice
lost
weight
develop
clinic
sign
mice
surviv
challeng
day
postinfect
lung
harvest
viral
load
assay
titrat
vero
cell
qrtpcr
rtpcr
analysi
genom
rna
indic
viru
present
day
howev
subgenom
mrna
transcript
indic
activ
replic
detect
replic
viru
could
cultur
lung
homogen
furthermor
mice
develop
pulmonari
patholog
coleman
et
al
analysi
merscov
host
receptor
express
immunohistochemistri
rtpcr
indic
low
level
express
lung
coleman
et
al
earli
studi
bind
effici
merscov
protein
rbd
mous
cell
cell
line
show
low
bind
effici
raj
et
al
tabl
collect
studi
demonstr
mice
natur
nonpermiss
merscov
inbr
strain
repres
suitabl
small
anim
model
base
success
hamster
model
sarscov
similarli
evalu
model
merscov
infect
de
wit
et
al
syrian
hamster
given
either
tcid
intratrach
inocul
tcid
via
aerosol
anim
monitor
clinic
diseas
nasal
oropharyng
urogenit
rectal
swab
collect
daili
day
postinfect
inocul
anim
display
clinic
sign
weight
loss
swab
neg
viral
rna
qrtpcr
de
wit
et
al
tissu
collect
day
postinfect
day
vrna
could
detect
lung
spleen
mandibular
lymph
node
qrtpcr
signific
histopatholog
observ
lung
trachea
kidney
brain
determin
hamster
infect
mx
gene
express
assay
indic
innat
immun
respons
merscov
inocul
anim
mx
express
similar
mockinfect
infect
anim
verifi
host
receptor
merscov
express
hamster
immunohistochemistri
perform
express
high
level
bronchiolar
epithelium
smooth
muscl
lung
also
glomerular
pariet
epithelium
nerv
tissu
kidney
de
wit
et
al
collect
result
indic
similar
mice
hamster
permiss
merscov
howev
contrast
mice
hamster
show
high
level
express
potenti
overcom
host
factor
may
limit
infect
rodent
ferret
evalu
model
merscov
four
anim
inocul
intranas
intratrach
tcid
nasal
throat
swab
collect
interv
day
postinfect
assay
viral
replic
viru
recov
swab
qrtpcr
analysi
demonstr
low
level
viral
rna
present
day
postinfect
ferret
also
fail
seroconvert
evid
anim
infect
subsequ
experi
primari
ferret
kidney
cell
shown
resist
merscov
infect
despit
high
level
express
transfect
express
plasmid
human
primari
ferret
kidney
cell
render
cell
suscept
merscov
infect
demonstr
ferret
major
host
restrict
factor
vitro
experi
chimer
humanferret
construct
demonstr
receptorbind
domain
rbd
respons
rel
resist
suscept
ferret
cell
infect
merscov
find
demonstr
ferret
like
hamster
mice
suitabl
model
merscov
infect
two
speci
nhp
evalu
model
merscov
infect
includ
rhesu
macaqu
common
marmoset
de
wit
et
al
falzarano
et
al
munster
et
al
yao
et
al
speci
suscept
merscov
infect
howev
extent
replic
diseas
sever
vari
upon
combin
intranas
intratrach
oral
ocular
inocul
tcid
strain
rhesu
macaqu
develop
mild
clinic
sign
consist
decreas
food
intak
nasal
swell
increas
respiratori
rate
elev
white
blood
cell
count
earli
infect
day
pi
de
wit
et
al
munster
et
al
anim
surviv
design
endpoint
day
postinfect
vrna
detect
nasal
swab
day
anim
clear
day
replic
viru
could
recov
lung
tissu
munster
et
al
titer
decreas
day
postinfect
examin
viral
dissemin
throughout
respiratori
tract
qrtpcr
demonstr
vrna
could
detect
nasal
mucosa
trachea
mediastin
lymph
node
conjunctiva
oronasopharynx
bronchi
day
viral
load
decreas
day
vrna
could
detect
nasal
mucosa
conjunctiva
later
time
point
de
wit
et
al
gross
examin
multipl
organ
day
reveal
patholog
restrict
lung
lung
lobe
contain
lesion
consist
observ
vrna
could
detect
kidney
bladder
histopatholog
analysi
found
anim
display
mild
mark
interstiti
pneumonia
day
progress
abund
alveolar
edema
format
hyalin
membran
day
de
wit
et
al
munster
et
al
analog
studi
four
rhesu
macaqu
intratrach
inocul
tcid
two
anim
maintain
day
two
anim
necropsi
day
pi
anim
show
increas
temperatur
day
reduc
water
intak
surviv
infect
rna
detect
nasal
oropharyng
cloacal
swab
collect
regular
interv
radiograph
imag
day
show
interstiti
infiltr
indic
pneumonia
replic
viru
isol
lung
sampl
day
viru
could
isol
tissu
includ
trachea
brain
kidney
yao
et
al
similar
previou
studi
gross
examin
reveal
lesion
restrict
lung
microscop
analysi
show
multifoc
mild
moder
interstiti
pneumonia
anim
also
develop
serum
neutral
antibodi
respons
detect
day
peak
day
remain
elev
day
yao
et
al
taken
togeth
studi
show
infect
rhesu
macaqu
merscov
result
transient
lung
infect
associ
pneumonia
discrep
extent
viru
replic
respiratori
tract
observ
nasal
swell
isol
viru
nasal
swab
like
reflect
use
multipl
inocul
rout
earlier
studi
anim
show
mild
clinic
diseas
earli
infect
mortal
observ
thu
rhesu
macaqu
recapitul
sever
infect
observ
human
case
howev
ribavirin
evalu
model
shown
limit
infect
falzarano
et
al
base
model
merscov
interact
common
marmoset
evalu
model
merscov
falzarano
et
al
recapitul
sever
diseas
marmoset
given
total
tcid
via
combin
intranas
oral
ocular
intratrach
rout
clinic
diseas
rang
moder
sever
anim
show
increas
respiratori
rate
decreas
bodi
temperatur
loss
appetit
decreas
activ
peak
clinic
ill
observ
day
nine
anim
euthan
due
sever
diseas
radiolog
evalu
reveal
evid
moder
sever
interstiti
infiltr
lower
lung
lobe
day
day
remain
anim
reduc
infiltr
indic
recoveri
day
throat
swab
nasal
swab
posit
vrna
viral
load
nose
throat
swab
decreas
day
vrna
consist
isol
throat
swab
proport
anim
late
day
postinfect
respiratori
tract
vrna
could
detect
day
conjunctiva
nasal
mucosa
trachea
mediastin
lymph
node
lung
lobe
addit
two
anim
show
evid
viremia
vrna
detect
blood
vrna
detect
multipl
organ
includ
kidney
liver
heart
indic
system
dissemin
viru
howev
given
anim
inocul
via
multipl
rout
may
facilit
system
infect
spread
throughout
respiratori
tract
histopatholog
analysi
day
reveal
acut
bronchointerstiti
pnemonia
viral
antigen
present
region
patholog
chang
day
acut
pneumonia
still
promin
type
ii
pneumocyt
hyperplasia
consolid
pulmonari
fibrin
result
hyalin
membran
format
consist
sever
lung
infect
type
pneumocyt
bronchiolar
epitheli
cell
smooth
muscl
cell
found
express
falzarano
et
al
thu
common
marmoset
reproduc
sever
featur
merscov
infect
potenti
use
evalu
novel
therapi
human
use
understand
restrict
merscov
replic
small
anim
evid
host
restrict
level
sequenc
sought
crystal
structur
protein
bound
solv
lu
et
al
interfac
protein
rbd
residu
protein
rbd
direct
contact
residu
see
tabl
interact
protein
rbd
two
major
bind
patch
patch
consist
residu
interact
neg
charg
surfac
consist
protein
rbd
addit
protein
rbd
form
hydrogen
bond
lu
et
al
second
major
bind
patch
consist
residu
residu
interact
protein
rbd
residu
residu
form
saltbridg
hydrogen
bond
protein
rbd
residu
respect
mention
initi
studi
chimer
protein
demonstr
incorpor
human
protein
rbd
residu
ferret
render
ferret
cell
suscept
merscov
infect
understand
role
protein
rbd
host
restrict
subsequ
studi
compar
merscov
protein
bind
affin
human
mous
sever
potenti
zoonot
reservoir
speci
includ
camel
hors
goat
bat
barlan
et
al
introduct
human
protein
bind
domain
mous
render
mous
cell
suscept
merscov
infect
thu
emphas
role
sequenc
host
restrict
comparison
human
bind
affin
speci
demonstr
human
highest
affin
protein
rbd
affin
decreas
follow
human
express
speci
render
cell
suscept
infect
mous
permit
infect
barlan
et
al
character
amino
acid
residu
interfac
protein
rbd
identifi
differ
mous
human
see
tabl
barlan
et
al
van
doremalen
et
al
cockrel
et
al
cockrel
et
al
introduct
human
residu
site
mous
result
highli
effici
infect
select
mutat
residu
associ
patch
bind
region
residu
patch
domain
restor
highli
effici
infect
indic
interact
patch
region
requir
high
affin
protein
bind
support
find
introduct
human
residu
associ
patch
respect
result
effici
infect
cockrel
et
al
context
hamster
model
express
human
nonpermiss
bhk
hamster
cell
render
cell
suscept
merscov
infect
indic
host
restrict
occur
level
receptor
comparison
hamster
human
sequenc
identifi
five
amino
acid
differ
protein
rbd
interfac
tabl
introduct
human
residu
hamster
permit
infect
hamster
cell
model
studi
suggest
two
residu
posit
larg
respons
host
restrict
agreement
studi
mous
show
mutat
also
present
hamster
decreas
infect
merscov
cockrel
et
al
collect
studi
demonstr
host
restrict
merscov
predominantli
dictat
sequenc
explor
addit
anim
model
sequenc
cotton
rat
see
tabl
found
protein
bind
residu
similar
hamster
ferret
suggest
cotton
rat
would
refractori
infect
inde
comparison
human
rhesu
macaqu
common
marmoset
sequenc
show
ident
residu
interact
merscov
protein
howev
differ
diseas
sever
rhesu
macaqu
common
marmoset
indic
host
factor
presenc
express
level
scleav
proteas
ie
cockrel
et
al
may
influenc
infect
diseas
sever
regardless
addit
host
factor
interact
merscov
protein
initi
predomin
focu
small
anim
model
develop
develop
anim
model
sarscov
demonstr
mous
adapt
gener
transgen
mice
express
result
enhanc
permiss
diseas
move
forward
anim
model
merscov
similar
strategi
util
mous
adapt
adapt
ferret
hamster
unlik
fruit
approach
infecti
viru
could
isol
anim
merscov
protein
fail
bind
speci
overcom
barrier
revers
genet
approach
could
use
introduc
mutat
merscov
protein
rbd
enhanc
promot
interact
differ
speci
residu
patch
underlin
residu
patch
ital
underlin
n
predict
sequenc
particular
util
outbr
anim
genet
manipul
host
receptor
would
challeng
demonstr
sarscov
gener
mice
express
human
may
rapid
strategi
yield
small
anim
model
inde
mice
transduc
adenoviru
vector
express
human
suscept
merscov
infect
develop
pneumonia
albeit
without
associ
mortal
transgen
mice
could
gener
via
tradit
method
use
doudna
charpenti
system
replac
mous
human
introduc
mous
carri
mutat
promot
protein
bind
either
transgen
strategi
develop
revers
genet
adapt
strain
replic
pathogenesi
character
meet
criteria
fda
anim
rule
despit
lack
suitabl
model
sever
group
develop
vaccin
therapeut
merscov
zhang
et
al
zhang
et
al
chan
et
al
hart
et
al
coleman
et
al
de
wild
et
al
dyall
et
al
kim
et
al
vaccin
candid
evalu
immunogen
antivir
evalu
vitro
medic
countermeasur
potenti
advanc
along
path
toward
regulatori
approv
suscept
small
anim
model
develop
use
conjunct
marmoset
model
concert
public
health
effort
novel
therapi
could
curb
ongo
merscov
epidem
reduc
morbid
mortal
associ
merscov
